0.00Open2.50Pre Close0 Volume4 Open Interest17.50Strike Price0.00Turnover123.63%IV11.76%PremiumDec 20, 2024Expiry Date0.50Intrinsic Value100Multiplier24DDays to Expiry2.00Extrinsic Value100Contract SizeAmericanOptions Type-0.4850Delta0.0750Gamma6.80Leverage Ratio-0.0436Theta-0.0063Rho-3.30Eff Leverage0.0172Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet